Latest News

The gaming giant has a potentially stock-moving event happening this week.

The high-growth digital advertising company faces some near-term headwinds.

Microvast shares jumped after reporting Q4 FY24 revenue of $113.39 million, surpassing estimates. Gross margin rose to 36.6%, while adjusted net loss narrowed significantly.

Don't be scared off up by the recent Trump FDA overhaul. The changes are very positive for Capricor Therapeutics moving forward (2025–2028).

Three stocks that were in rough spots at the end of 2024 rose at least 35% in the first quarter this year.

The Reserve Bank of Australia kept the monetary rate unchanged at 4.1% at its April meeting, leaving borrowing costs unchanged after a 25 basis point cut at its February meeting, in line with market expectations.

Since it joined the Dow industrials on Nov. 7, Nvidia stock is down nearly 30%.

A fundamental and technical analysis of (NASDAQ:TARS): Why the high growth investor may take a look at TARSUS PHARMACEUTICALS INC (NASDAQ:TARS).

Jacob DeWitte, CEO of Oklo Inc. (NYSE: OKLO), has reportedly sold a significant portion of his company stock, according to a filing with the Securities and Exchange Commission (SEC).

Palantir's revenue growth is still accelerating.

Asian stocks rebounded after a multi-day losing streak, driven by heightened market volatility as President Donald Trump prepared to unveil his tariff plan.

Based on technical and fundamental analysis of NASDAQ:WING we find: WINGSTOP INC (NASDAQ:WING) qualifies as a high growth stock and is consolidating.

XPeng delivered 33,205 Smart EVs in March, a 268% growth, and 94,008 in Q1 2025, a 331% increase. NIO delivered 15,039 vehicles, a 26.7% growth.